Laparoscopic pancreaticoduodenectomy: a systematic literature review
Background Laparoscopic pancreaticoduodenectomy (LPD) is gaining momentum, but there
is still uncertainty regarding its safety, reproducibility, and oncologic appropriateness. This …
is still uncertainty regarding its safety, reproducibility, and oncologic appropriateness. This …
[HTML][HTML] Borderline resectable pancreatic cancer: definitions and management
NE Lopez, C Prendergast, AM Lowy - World journal of …, 2014 - ncbi.nlm.nih.gov
Pancreatic cancer is the fourth leading cause of cancer death in the United States. While
surgical resection remains the only curative option, more than 80% of patients present with …
surgical resection remains the only curative option, more than 80% of patients present with …
Efficacy of preoperative mFOLFIRINOX vs mFOLFIRINOX plus hypofractionated radiotherapy for borderline resectable adenocarcinoma of the pancreas: the A021501 …
Importance National guidelines endorse treatment with neoadjuvant therapy for borderline
resectable pancreatic ductal adenocarcinoma (PDAC), but the optimal strategy remains …
resectable pancreatic ductal adenocarcinoma (PDAC), but the optimal strategy remains …
Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators
BACKGROUND: Experience with preoperative therapy for other cancers has led to an
assumption that borderline resectable pancreatic cancers can be converted to resectable …
assumption that borderline resectable pancreatic cancers can be converted to resectable …
[HTML][HTML] Vascular resection for pancreatic cancer: 2019 French recommendations based on a literature review from 2008 to 6-2019
JR Delpero, A Sauvanet - Frontiers in Oncology, 2020 - frontiersin.org
Introduction: Vascular resection remains a subject of debate in the management of
Pancreatic Ductal Adenocarcinoma (PDAC). These French recommendations were drafted …
Pancreatic Ductal Adenocarcinoma (PDAC). These French recommendations were drafted …
Approach to patients with pancreatic cancer without detectable metastases
The poors outcomes associated with pancreatic cancer clearly reflect the advanced stage of
disease at diagnosis for most patients. Through this lens, it is easy to lose sight of the fact …
disease at diagnosis for most patients. Through this lens, it is easy to lose sight of the fact …
Locally advanced pancreatic adenocarcinoma: reassessment of response with CT after neoadjuvant chemotherapy and radiation therapy
C Cassinotto, A Mouries, JP Lafourcade, E Terrebonne… - Radiology, 2014 - pubs.rsna.org
Purpose To prospectively evaluate the utility of computed tomography (CT) for determination
of tumor response and prediction of resectability after neoadjuvant combined chemotherapy …
of tumor response and prediction of resectability after neoadjuvant combined chemotherapy …
An evaluation of the accuracy of CT when determining resectability of pancreatic head adenocarcinoma after neoadjuvant treatment
C Cassinotto, J Cortade, G Belleannée… - European journal of …, 2013 - Elsevier
BACKGROUND: To evaluate the accuracy of MDCT for determination of resectability R0
after neoadjuvant therapy in patients with pancreatic head adenocarcinoma locally …
after neoadjuvant therapy in patients with pancreatic head adenocarcinoma locally …
Pancreatic adenocarcinoma with venous involvement: is up-front synchronous portal-superior mesenteric vein resection still justified? A survey of the Association …
JR Delpero, JM Boher, A Sauvanet, YP Le Treut… - Annals of surgical …, 2015 - Springer
Background Venous resection (VR) during pancreatectomy has been reported to neither
increase mortality nor morbidity and to provide similar survival outcomes in same stage …
increase mortality nor morbidity and to provide similar survival outcomes in same stage …
Pathology reporting of pancreatic cancer following neoadjuvant therapy: challenges and uncertainties
C Verbeke, M Löhr, JS Karlsson, M Del Chiaro - Cancer treatment reviews, 2015 - Elsevier
An increasing number of studies investigate the use of neoadjuvant treatment for ductal
adenocarcinoma of the pancreas. While a strong rationale supports this approach, study …
adenocarcinoma of the pancreas. While a strong rationale supports this approach, study …